secwatch.observer — SEC 8-K summary
======================================

Issuer:     Fortrea Holdings Inc. (FTRE)
CIK:        0001965040
Form:       8-K
Filed at:   2025-09-22T23:59:59+00:00
Accession:  0001628280-25-042341
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Fortrea appoints William Sharbaugh as Class III director effective Sept 22, 2025
--------------------------------------------------------------------------------

- William Sharbaugh appointed to Fortrea Board as Class III director, effective Sept 22, 2025.
- Sharbaugh served as COO of PPD, Inc. from 2007-2021 and held roles at Bristol-Myers Squibb and Merck.
- No committee assignments yet; will receive standard non-employee director compensation per existing policy.
- Sharbaugh currently chairs Ora LLC and serves on boards of Launch Therapeutics, Alcami, and BioCare.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1965040/000162828025042341/0001628280-25-042341-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1965040/000162828025042341/ftre-20250919.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-042341

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer